US74374N1028 - Common Stock
Provention Bio (PRVB) rose 3.1% in premarket trading after the HSR antitrust waiting period for the company's sale to Sanofi (SNY) expired
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
The pharma giant has outperformed the broader market over the past 12 months.
A market rally is underway, but bank stocks kept tumbling.
Provention Bio is currently a partner of Sanofi. It should soon become a part of the big French drugmaker.
The cancer-focused biotech delivered a strong earnings report.
On a volatile market day, companies are still looking for smart combinations.
/PRNewswire/ -- Ademi LLP is investigating Provention Bio (Nasdaq: PRVB) for possible breaches of fiduciary duty and other violations of law in its transaction...
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Stocks see-sawed during Monday#39;s intraday trading as investors weighed a proposal to backup all of the depositors in the defunct Silicon Valley Bank.Looking at the specific stocks that...
Pfizer expects Seagen to add at least $10 billion to its topline in 2030.
First Republic Bank (FRC) stock is falling hard on Monday as bank stocks react to the recent drama surrounding SVB Financial (SIVB).
Science 37 (SNCE) stock is rising higher on Monday following news of inducement equity awards for its Metasite employees.
Provention Bio (PRVB) stock is rocketing higher on Monday following news that Sanofi (SNY) is acquiring the company for $2.9 billion.
We're starting off the week with a breakdown of the biggest pre-market stock movers traders need to know about for Monday!